Skip to main content

Russell Investments Group, Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1692234 Seattle, WA

Position in NBIX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$55,460,607
+$26,510,092 QoQ
Shares Held
329,065
+49.7% QoQ
Ownership
0.324%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#55
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (15.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
329,065 $55,460,607

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $55,460,607 329,065
2026-03-31 $28,950,515 219,755
2025-12-31 $17,700,800 124,803
2025-09-30 $15,711,604 111,922
2025-06-30 $10,579,194 84,169
2025-03-31 $11,126,132 100,598
2024-12-31 $17,228,618 126,217
2024-09-30 $24,285,722 210,777
2024-06-30 $39,753,724 288,761
2024-03-31 $48,177,798 349,317
2023-12-31 $53,399,558 405,279
2023-09-30 $46,557,337 413,843
2023-06-30 $37,754,322 400,364
2023-03-31 $34,696,390 342,782
2022-12-31 $18,678,622 156,385
2022-09-30 $12,993,409 122,337
2022-06-30 $14,846,202 152,300
2022-03-31 $13,170,561 140,486
2021-12-31 $4,332,682 50,871
2021-09-30 $3,282,325 34,223
2021-06-30 $2,126,829 21,854
2021-03-31 $1,663,072 17,101
2020-12-31 $1,344,870 14,031
2020-09-30 $1,963,681 20,421
2020-06-30 $9,670,330 79,265
2020-03-31 $9,384,527 108,429